Glenn Esses, MD
Vascular Surgery · Mobile, ALNPI 1912900283
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.5% of the total across 180 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 22.8% — the pattern of someone who eats at a lot of different presentations.
Across 180 payments — averaging $37.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Boston Scientific$1K
- Endologix LLC$571
- Cook Medical LLC$353
- Baxter Healthcare$319
- Silk Road Medical, Inc.$254
- plus $2K from 30 others
What the payments were for
- Travel & lodging$120%
- Food & beverage$6,45495%
- Education$2934%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 32 | $1,540 |
| Boston Scientific | 48 | $1,472 |
| Endologix LLC | 2 | $571 |
| Cook Medical LLC | 13 | $353 |
| Baxter Healthcare | 5 | $319 |
| Silk Road Medical, Inc. | 4 | $254 |
| Organogenesis Inc. | 2 | $201 |
| Johnson & Johnson | 8 | $193 |
| Angiodynamics, Inc. | 5 | $192 |
| Abbott | 11 | $179 |
| Veryan Medical Incorporated | 3 | $166 |
| Atricure, Inc. | 1 | $143 |
| Inari Medical, Inc. | 1 | $125 |
| Tactile Systems Technology Inc | 6 | $120 |
| Polynovo North America LLC | 1 | $95 |
| Venclose Inc. | 2 | $80 |
| Pfizer | 4 | $79 |
| Polarityte, Inc. | 2 | $66 |
| Cardiovascular Systems Inc. | 5 | $62 |
| Triad Life Sciences Inc. | 2 | $52 |
| Convatec Inc. | 2 | $47 |
| CSL Behring | 2 | $45 |
| Bard Peripheral Vascular, Inc. | 2 | $44 |
| Ossur Americas, Inc. | 1 | $44 |
| Lemaitre Vascular, Inc. | 3 | $42 |
| Centerline Biomedical Inc. | 1 | $41 |
| Bioventus LLC | 2 | $37 |
| W. L. Gore & Associates, Inc. | 1 | $37 |
| Biotronik Inc. | 1 | $34 |
| Medline Industries LP | 2 | $26 |
| Cordis US CORP. | 1 | $25 |
| Kerecis Limited | 1 | $19 |
| Biocompatibles, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Davol Inc. | 1 | $13 |
| Biowound Solutions, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENDURANT IIS$566
- Torus Stent Graft System$292
- ENDOCROSS Device$292
- AFX2 Bifurcated Endograft System$279
- JETSTREAM SC$255
- ATRICURE CRYOICE CRYOSPHERE CRYOABLATION SYSTEM$143
- ATRICURE CRYOICE CRYOABLATION SYSTEM (CRYO2)$143
- Endurant$141
- JETSTREAM$128
- FLOWTRIEVER CATHETER, S$125
- CT THROMBECTOMY SYSTEM KIT$125
- COSEAL$122
- ELUVIA$120
- ARTISS$120
- PuraPly$118
- GENERAL VASCULAR INTERVENTION$116
- BioMimics 3D Vascular Stent System$116
- WATCHMAN FLX$113
- ENROUTE Transcarotid Neuroprotection System$111
- ENROUTE Transcarotid Stent System$111
How this compares
$6,760 in reported general payments places this provider in the 55th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XareltoRivaroxaban | 71 | $47,497 |
| EliquisApixaban | 49 | $32,018 |
| Prasugrel Hcl | 26 | $1,176 |
| ClopidogrelClopidogrel Bisulfate | 104 | $917 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 98 | $630 |
| Rosuvastatin Calcium | 22 | $190 |
| Methylprednisolone | 11 | $71 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $57 |
| Levofloxacin | 12 | $41 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonXarelto | $193 | $47,49771 claims |
| PfizerEliquis | $79 | $32,01849 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 61 vascular surgery providers in Alabama.
Other vascular surgery in Mobile
- Mina JacobMobile$19K
- Benjamin MakamsonMobile$18K
- Lee FergusonMobile$13K
- Cullen McCarthyMobile$8K
- Michael DoMobile$7K
- Lewis LyonsMobile$6K
- William HardyMobile$3K
- Melanie RoseMobile$3K
- Ralph PfeifferMobile$2K
- Albert PacificoBirmingham$5.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.